Hacking Cancer Together

We dream big. We imagine a world where cancer is curable.

The Latest at the Parker Institute

Intestine
Research Updates

Could probiotics reduce immunotherapy’s chances of working in cancer patients?

November 8, 2018
Tcell
Announcements, Research Updates

PICI @ SITC 2018 Annual Meeting #SITC2018

November 7, 2018
Cancer Cell In Human Body
Press Releases

The Parker Institute for Cancer Immunotherapy Partners with Xyphos Biosciences to Develop Universal Programmable CAR-T Cells for Cancer Treatment

October 18, 2018
More

 The Parker Institute for Cancer Immunotherapy enables real collaboration, accelerating ambitious research to deliver new immunotherapies engineered to save lives.

World-renowned experts from leading cancer centers are at the forefront of our research.

Memorial Sloan Kettering Cancer Center
Stanford Medicine
UCLA
UCSF
Penn Medicine
MD Anderson Cancer Center
Fred Hutch Logo White
About Our Model
Parker Institute Parker Institute @parkerici #Immunotherapy pioneer and Parker Institute director Carl June of @PennMedicine hits the stage tomorrow at #TEDMED… https://t.co/QPRS9Wnl9t 25 minutes ago
Parker Institute Parker Institute @parkerici PICI's Dr Jedd Wolchok (@wolchokj) of @sloan_kettering on the progress made with cancer vaccines, especially in com… https://t.co/uMAtE2Qe3g 1 hour ago
Parker Institute Parker Institute @parkerici RT @AtlanticLIVE: The idea of sequencing a person's tumor to create a personalized vaccine seemed like science fiction very recently. There… 2 hours ago

Research Projects

Our investigators collaborate on high-risk, high-reward research projects

Our Partners

Working together to get much needed treatments to patients faster

For Patients

Furthering research to get treatments to patients faster

Our Model

A new approach to accelerate cancer breakthroughs

© 2018 All Rights Reserved
Member Center Login

Get Email Updates